or Try an Advanced Search...

    Antimicrobial Resistance Stocks List

    Symbol Grade Name % Change
    MCRB F Seres Therapeutics, Inc. -4.79
    SPRO F Spero Therapeutics, Inc. -0.83
    MTNB F Matinas Biopharma Holdings, Inc. -0.07
    OPGN F OpGen, Inc. -10.00
    View As Page of Charts
    Related Industries: Biotechnology Diagnostics & Research
    Related Stock Lists: Antibiotics Bacterial Infections Biopharmaceutical Evolutionary Biology Medicine Multi Drug Resistant Bacterial Infections Veterinary Medicine Aminoglycoside Autoimmune Disease Bacteria Bioinformatics Cdi Clinical Development Clostridioides Difficile Clostridium Difficile Clostridium Difficile Infection Colitis Diarrhea Digestive Diseases Drug Resistance

    Related ETFs - A few ETFs which own one or more of the above listed Antimicrobial Resistance stocks.

    Symbol Grade Name Weight
    QQQS C Invesco NASDAQ Future Gen 200 ETF 0.4
    IWC B iShares Microcap ETF 0.01
    SCHA B Schwab U.S. Small-Cap ETF 0.0
    VXF B Vanguard Extended Market ETF 0.0
    VHT D Vanguard Health Care ETF 0.0
    View all Antimicrobial Resistance ETFs...
    Compare ETFs
    Compare IWC to VHT Compare QQQS to SCHA Compare SCHA to VXF

        Antimicrobial Resistance Stocks Recent News

        Date Stock Title
        Nov 20 SPRO Grifols' Board Rejects Brookfield's Buyout Offer, Stock Down 8%
        Nov 19 SPRO FATE Presents Encourgaing Data From Lupus Study, Stock Gains
        Nov 19 SPRO CHMP Endorses AstraZeneca's Tagrisso for Expanded Use in NSCLC
        Nov 18 SPRO TenNor’s Phase III antibiotic trial meets all primary endpoints
        Nov 18 SPRO CHMP Endorses J&J's Rybrevant-Lazcluze Combo for Use in NSCLC
        Nov 17 SPRO Spero Therapeutics Third Quarter 2024 Earnings: Beats Expectations
        Nov 15 MCRB Seres Therapeutics Third Quarter 2024 Earnings: US$0.33 loss per share (vs US$0.37 loss in 3Q 2023)
        Nov 14 SPRO Spero Therapeutics, Inc. (SPRO) Reports Q3 Loss, Lags Revenue Estimates
        Nov 14 SPRO Spero Therapeutics Announces Third Quarter 2024 Operating Results and Provides a Business Update
        Related Industries: Biotechnology Diagnostics & Research
        Related Stock Lists: Antibiotics Bacterial Infections Biopharmaceutical Evolutionary Biology Medicine Multi Drug Resistant Bacterial Infections Veterinary Medicine Aminoglycoside Autoimmune Disease Bacteria Bioinformatics Cdi Clinical Development Clostridioides Difficile Clostridium Difficile Clostridium Difficile Infection Colitis Diarrhea Digestive Diseases Drug Resistance
        Antimicrobial Resistance

        Antimicrobial resistance (AMR) is the ability of a microorganism (such as bacteria, viruses, and some parasites) to resist the effects of medication that once could successfully treat the microorganism. When this happens, standard treatments become ineffective, infections persist and may spread to others.

        Browse All Tags